2 active not recruiting, 1 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 2, Terminated 1 |
Follow trimethaphan camsylate: new trials by email Literature Review of trimethaphan camsylate trials Research Report on trimethaphan camsylate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic Trimethaphan, Placebo - Multiple System Atrophy, Orthostatic Hypotension | Phase 1 | Active not recruiting | Vanderbilt University | 2 | 2016-04-01 | 2026-03-13 |
| Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension Trimethaphan, Nitroglycerin - Hypertension | Phase 1 | Active not recruiting | Vanderbilt University | 12 | 2015-04-01 | 2026-08-27 |
| Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension Angiotensin (1-7), Trimethaphan, Phenylephrine - Hypertension, Hypertension, Essential | Phase 1 | Terminated | Vanderbilt University | 24 | 2015-01-01 | 2024-01-09 |
Hypertension (2) · Essential Hypertension (1) · Hypotension, Orthostatic (1) · Multiple System Atrophy (1)
United States (3)
Italo Biaggioni, MD (2) · Italo Biaggioni, M.D. (1)